AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicotar M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glicotar M 80mg/500mg Tablet

Metformin/glimepiride 80mg/500mg tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by helping regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular meals and carry readily available glucose (e.g., sugary snacks, juice) to manage hypoglycemia. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Glicotar M 80mg/500mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Glicotar M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glicotar M 80mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid crushing, chewing, or breaking it. Consume Glicotar M 80mg/500mg tablets with a meal.

Common Side effects of Glicotar M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glicotar M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not chew, crush, or fracture it. Glicotar M 80mg/500mg tablets should be administered with a meal.

How Glicotar M 80mg/500mg Tablet works:

Each Glicotar M 80mg/500mg tablet combines the antidiabetic agents gliclazide (80mg) and metformin (500mg).

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glicotar M 80mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glicotar M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptionally, a physician might consider prescribing it in emergencies where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Glicotar M 80mg/500mg tablets are likely incompatible. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glicotar M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. In cases of severe kidney disease, Glicotar M 80mg/500mg tablets are contraindicated. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glicotar M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation at a low dose is typical; however, the medication is unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Glicotar M 80mg/500mg Tablet :

Should you forget a Glicotar M 80mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glicotar M 80mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glicotar M 80mg/500mg Tablet

Glicotar M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glicotar M 80mg/500mg Tablets may cause frequent adverse reactions such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Less common, but potentially severe, side effects include lactic acidosis. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Glicotar M 80mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Glicotar M 80mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare but potential complication of metformin use. Risk factors include pre-existing kidney impairment, advanced age, and significant alcohol consumption. Symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Glicotar M 80mg/500mg tablet use and seek immediate medical attention.
Indeed, prolonged Glicotar M 80mg/500mg Tablet consumption can lead to vitamin B12 insufficiency. This deficiency arises from the medication's disruption of vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this can result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of an annual dose, has been proposed by some investigators.
Patients with a history of hypersensitivity to Glicotar M 80mg/500mg Tablet components or inactive ingredients should not use this medication. Similarly, its administration is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glicotar M 80mg/500mg tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and elevates the probability of lactic acidosis.
Glicotar M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when coupled with a suitable diet and exercise regimen. Gliclazide's mechanism involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose output and augments insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes.
Glicotar M 80mg/500mg Tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Less frequent, but potentially serious, side effects include lactic acidosis. Prolonged administration might result in vitamin B12 deficiency.
Indeed, Glicotar M 80mg/500mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Glicotar M 80mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. It's preventable by avoiding use in individuals with pre-existing kidney problems, the elderly, or those who consume significant alcohol. Symptoms may involve muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Glicotar M 80mg/500mg Tablet use and seek immediate medical attention.
Indeed, prolonged Glicotar M 80mg/500mg Tablet consumption can lead to vitamin B12 insufficiency. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Left unaddressed, this can result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive alterations, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum annually, is recommended by some studies.
Patients with hypersensitivity to Glicotar M 80mg/500mg Tablet ingredients or excipients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or metabolic acidosis, such as diabetic ketoacidosis.
Combining Glicotar M 80mg/500mg tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and elevates the likelihood of lactic acidosis.
Glicotar M 80mg/500mg Tab...
70
MRP 85
17% off